The UK is the first country in the world to approve a coronavirus vaccine from the vaccine companies BioNTech and Pfizer. First, the elderly and healthcare workers can receive a vaccine that has been proven effective and does not cause serious side effects.

Coronavirus: the second wave, the second closure

Later than expected by many, but in mid-November, the Hungarian government also decided to try to curb the second wave of the coronavirus epidemic by introducing restrictions. At the time of the decision, 5,000 new infections had been identified per day and the number of deaths from the virus was mostly between 50 and 100 in 24 hours. The first step is a partial closure, but how effective it is is questionable. Follow our news!

It has been declared safe by the Medicines and Healthcare Products Regulatory Agency (MHRA), so the BioNTech and Pfizer vaccines can be widely used in the UK. BBC from Wednesday’s news.

Therefore, the BioNTech-Pfizer vaccine is the first in the world to be used in the UK.

The United Kingdom has contracted 40 million doses of the vaccine with a 95% effectiveness, which is enough to immunize 20 million people, two per vaccine per person. The drug can be received in the first round by key groups (such as the elderly, health workers), and this will happen in the next few days.

The two companies announced in early November that they had been able to develop an effective vaccine against the coronavirus epidemic. The vaccine was rated at 90 percent based on data collected in its third phase of incineration, but rose to 95 percent after further testing. A vaccine called BNT162b2, which contains the genetic code for the virus, teaches the body how to fight Covid-19 and build immunity against the pathogen.

BionTech was developed in record time, and researchers went from vaccine-related concepts to completed vaccination in 10 months. But, as clinical trials in more than 43,000 people in six countries have shown, it works and does not cause stronger and more serious side effects. The only disadvantage of the drug compared to other similar materials is that it must be stored at minus 70 degrees Celsius, and the price is also a little more expensive: BBC It is estimated at 15 pounds (about 6 thousand guilders) per vaccination. The Oxford and Russia vaccines cost £ 3 and £ 7.50 respectively.

Although completing vaccinations is an important advance in scientific life, experts believe that we cannot rest: regardless of vaccinations, we must keep our distance and wear a mask to reduce the number of infections. The latter not only sought to be emphasized by British researchers, but also confirmed by German and French experts.

The vaccine will also be transferred to EU Member States, but the corresponding authorization process has not yet been completed. A day earlier, on Tuesday, the vaccine developer submitted the necessary documents to the Amsterdam-based European Medicines Agency (EMA), which is trying to reach a decision using an expedited procedure. If licensed, the vaccine could begin to be marketed and used in Europe before the end of the year.

If you ever want to know about similar things, check out the Facebook page in the HVG Tech section.



The number of independent power editorial boards is steadily declining, and those that still exist are trying to stay afloat in a growing headwind. At HVG we persevere, we do not give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to support us, support us, join our membership and renew it.

And we promise to keep doing our best for you in all circumstances!